CAMH research suggests potential targets for prevention and early identification of psychotic disorders
New study is largest known of its kind to track past mental health service use for young people diagnosed with a psychotic disorder
2024-06-21
(Press-News.org) A new study by the Centre for Addiction and Mental Health (CAMH), entitled Mental Health Service Use Before First Diagnosis of a Psychotic Disorder and published in JAMA Psychiatry, found that nearly 75 per cent of young Ontarians with a psychotic disorder had at least one mental health service visit within the three years prior to their first diagnosis of the disorder.
The retrospective cohort study—one of the largest of its kind—suggests that youth with a psychotic disorder are nearly four times as likely to have a previous mental health-related hospital admission, twice as likely to have a mental health-related emergency department visit, and more likely to have a past diagnosis of substance use disorder compared to youth diagnosed with a mood disorder.
“Our findings suggest that these factors—prior mental health-related hospital admissions and emergency department visits, and prior diagnosis of substance use disorder—may indicate increased risk for a psychotic disorder,” says Dr. Nicole Kozloff, Co-Director of the Slaight Family Centre for Youth in Transition at CAMH. “These results are remarkably consistent with other jurisdictions outside Canada, and should guide further research into detecting and intervening earlier in the course of psychotic illness.”
As part of the study, the researchers used information held by ICES on health service use and other linked data to examine previous mental health use in Ontarians aged 15-29 years who were later diagnosed with a psychotic disorder between April 1, 2012 and March 31, 2018. The team identified more than 10,000 individuals with a first diagnosis of psychotic disorder and matched them with individuals who were diagnosed with a mood disorder.
“Those at risk for psychosis are ‘hiding in plain sight,’” says Dr. Aristotle Voineskos, Vice President, Research at CAMH and Director of the Campbell Family Mental Health Research Institute. “These data provide a very different picture of who is at risk for psychosis, and also suggest the opportunity moving forward to examine whether effective treatment for prior conditions may change the risk for psychosis.”
The early findings from this research inspired the launch of the Toronto Adolescent & Youth (TAY) Cohort Study at CAMH. This five-year study is tracking 1,500 children and youth presenting for mental health services, examining their biology, education and cognition, social factors, and service use patterns. The goal is to increase understanding of who is at risk for psychosis and, most importantly, how to mitigate that risk via earlier intervention.
This research underpins a key pillar of CAMH’s new strategic plan, Get Upstream, which aims to position the hospital at the forefront of early mental illness identification, prevention strategies, and timely access to high-quality care.
CAMH is already a leader in both research and clinical care for youth experiencing psychosis. The Slaight Family Centre for Youth in Transition’s unique integrated approach translates the latest clinical and scientific evidence into better intervention and recovery strategies, making a real difference in the lives of young people. The Slaight Centre houses an outpatient early psychosis intervention program, clinical high risk program, and an inpatient early psychosis unit, which treat more than 425 patients on average each month between the ages of 14 to 29 years old.
– 30 –
About the Centre for Addiction and Mental Health (CAMH)
CAMH is Canada's largest mental health and addiction teaching hospital and a world leading research centre in this field. CAMH combines clinical care, research, education, policy development and health promotion to help transform the lives of people affected by mental illness and addiction. CAMH is fully affiliated with the University of Toronto, and is a Pan American Health Organization/World Health Organization Collaborating Centre. For more information, please visit camh.ca or follow @CAMHnews on X, formerly Twitter.
Media Contact:
CAMH Media Relations
media@camh.ca
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-06-21
Scientists at the Victor Chang Cardiac Research Institute in Australia have produced a first of its kind integrated map of heart cells which unlocks the process of cardiac fibrosis – a major cause of heart failure.
The discovery opens new avenues to develop targeted drugs to prevent scarring damage caused after a heart attack.
During and after a heart attack, the heart’s muscles are damaged leading to the formation of scar tissue which lacks the elasticity and contractility of healthy heart muscle. This damage is permanent and can affect ...
2024-06-21
Some 1,000 years ago, a small band of Polynesians sailed thousands of miles across the Pacific to settle one of the world’s most isolated places—a small, previously uninhabited island they named Rapa Nui. There, they erected hundreds of “moai,” or gigantic stone statues that now famously stand as emblems of a vanished civilization. Eventually, their numbers ballooned to unsustainable levels; they chopped down all the trees, killed off the seabirds, exhausted the soils and in the end, ruined their environment. Their population and civilization collapsed, with just a few thousand people remaining when ...
2024-06-21
Chronic pain affects millions worldwide, and current treatments often rely on opioids, which carry risks of addiction and overdose.
Non-addictive alternatives could revolutionize pain management, and new research targeting the human protein which regulates cold sensations, brings scientists closer to developing pain medications that don't affect body temperature and don't carry the risks of addiction.
Research published in Science Advances on June 21, led by Wade Van Horn, professor in Arizona State University’s School of Molecular Sciences and Biodesign ...
2024-06-21
Elena Beccalli will be rector of the Università Cattolica del Sacro Cuore on 1st July for the four-year term 2024–2028. After being appointed by the University's Board of Directors, which convened today, Thursday 20 June 2024, Professor Beccalli succeeds Professor Franco Anelli. She is the first woman appointed to this role in the history of our university.
The decision of the Board of Directors follows the appointment of Professor Elena Beccalli, Dean of the School of Banking, Finance, and Insurance ...
2024-06-21
Seattle, WA — June 21, 2024 — Researchers at the Pacific Northwest Research Institute (PNRI) and collaborating institutions have made a groundbreaking discovery that could significantly advance our understanding of genomic disorders. Their latest study, funded by the National Institutes of Health[1] and published in the journal Cell Genomics, reveals how specific DNA rearrangements called inverted triplications contribute to the development of various genetic diseases.
Understanding the Study
Genomic disorders occur when there are changes or mutations in DNA that disrupt normal biological functions. These can lead ...
2024-06-21
(Toronto, June 20, 2024) A new review in the Journal of Medical Internet Research, published by JMIR Publications, found that community-dwelling older adults are more likely to continue using wearable monitoring devices (WMDs), like trackers, pedometers, and smartwatches, if they receive support from health care professionals or peers.
The research team from The Hong Kong Polytechnic University, led by Dr. Arkers Kwan Ching Wong, reviewed data from 3 randomized controlled trials involving over 150 older adults. The evaluation showed that the interventions that focused on increasing awareness of being monitored and used collaborative goal-setting and feedback tools, such as the SystemCHANGE ...
2024-06-21
Dr. John Kirwan, Executive Director of Pennington Biomedical Research Center, is serving as a co-principal investigator on the Pathobiology in RECOVER of Metabolic and Immune Systems, or PROMIS, study. The study has been awarded more than $802,000 by the National Institutes of Health to identify potential causes of Long COVID.
“The PROMIS study will help us better understand what is driving Long COVID,” Dr. Kirwan said. “In the early days of the pandemic, Pennington Biomedical directed its resources to address the urgent health needs of our population. Now with estimates that more than 25 percent of people in the U.S. who had COVID have experienced ...
2024-06-21
An orange teeming with antioxidants and other health benefits may be a shot in the arm for consumers and citrus growers, if the fruit is stored at cool temperatures, a new University of Florida study shows.
But it’s too soon to know if the so-called “blood oranges” are a viable crop for the Florida citrus industry, says Ali Sarkhosh, a UF/IFAS associate professor of horticultural sciences. Sarkhosh’s post-doctoral associate Fariborz Habibi explains further.
“Although blood oranges typically command higher prices than other common varieties, such as navel or ...
2024-06-21
According to a National Poll on Healthy Aging, 93% of people in the U.S. between 50-80 years old report experiencing at least one form of ageism from other people. Internalized ageism is when a person believes ageist ideas about themselves, such as thinking they had a “senior moment” or thinking they are too old to learn new technology. Internalizing ageist stereotypes can impact older people’s mental and physical health, including sexual health. Various aspects of older adults’ sexual ...
2024-06-21
DURHAM, N.C. – Biomedical engineers at Duke University have developed a new technique to better understand and test treatments for a group of extremely rare muscle disorders called dysferlinopathy or limb girdle muscular dystrophies 2B (LGMD2B). The approach grows complex, functional 3D muscle tissue from stem cells in the laboratory, creating a platform that replicates patient symptoms and treatment responses.
In its debut study, researchers reveal some of the biological mechanisms underlying the characteristic loss of mobility caused by LGMD2B. They also demonstrate that a combination of existing treatments may be able to alleviate some ...
LAST 30 PRESS RELEASES:
[Press-News.org] CAMH research suggests potential targets for prevention and early identification of psychotic disorders
New study is largest known of its kind to track past mental health service use for young people diagnosed with a psychotic disorder
